Longevity in Slovenia: Past and potential gains in life expectancy by age and causes of death

• Published in: Zdravstveno varstvo Vol. 56; no. 2; pp. 124 - 130
• Main Authors: Lotrič Dolinar, Aleša, Došenović Bonča, Petra, Sambt, Jože
• Format: Journal Article
• Language: English
• Published: Poland De Gruyter 01-06-2017; Institute of Public Health of the Republic of Slovenia; Sciendo
• Subjects: Age; age decomposition; Birth; cause elimination; causes of death; Death; Death & dying; Decision analysis; Decision making; Disease control; Diseases; dolgoživost; Life expectancy; life expectancy at birth; Life span; Life tables; Longevity; Men; Mortality; Neoplasms; Original Scientific; potencialno podaljšanje; potential gains in life expectancy; razčlenjevanje po starosti; Resource allocation; Slovenia; Slovenija; tablice umrljivosti; umrljivost; vzroki smrti; življenjskega pričakovanja; Slovenia; potential gains in life expectancy; age decomposition; cause elimination; causes of death; life expectancy at birth; mortality; longevity; Slovenia; life tables
• ISSN: 0351-0026; 1854-2476; 1854-2476
• DOI: 10.1515/sjph-2017-0016

In Slovenia, longevity is increasing rapidly. From 1997 to 2014, life expectancy at birth increased by 7 and 5 years for men and women, respectively. This paper explores how this gain in life expectancy at birth can be attributed to reduced mortality from five major groups of causes of death by 5-year age groups. It also estimates potential future gains in life expectancy at birth.
The importance of the five major causes of death was analysed by cause-elimination life tables. The total elimination of individual causes of death and a partial hypothetical adjustment of mortality to Spanish levels were analysed, along with age and cause decomposition (Pollard).
During the 1997-2014 period, the increase in life expectancy at birth was due to lower mortality from circulatory diseases (ages above 60, both genders), as well as from lower mortality from neoplasms (ages above 50 years) and external causes (between 20 and 50 years) for men. However, considering the potential future gains in life expectancy at birth, by far the strongest effect can be attributed to lower mortality due to circulatory diseases for both genders. If Spanish mortality rates were reached, life expectancy at birth would increase by more than 2 years, again mainly because of lower mortality from circulatory diseases in very old ages.
Life expectancy analyses can improve evidence-based decision-making and allocation of resources among different prevention programmes and measures for more effective disease management that can also reduce the economic burden of chronic diseases.